INNOVATE Corp

VATE

Market cap $219M

NEW YORK, June 01, 2026 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that HC2 Broadcasting Holdings Inc. (“Broadcasting”) closed on a refinancing transaction and that Broadcasting and HC2 Broadcasting Holdco, LLC (“HC2 Holdco”), subsidiaries of INNOVATE, have entered into a definitive agreement pursuant to which INNOVATE will sell a controlling interest in Broadcasting to CONX CORP. (“CONX”), subject to the satisfaction of customary closing conditions, including the receipt of required regulatory approvals. After the closing of the transaction, it is expected that CONX will own approximately 75% of Broadcasting and INNOVATE will own approximately 25% of Broadcasting through HC2 Holdco.

VATE's Q1 revenues jump 33% as AI-driven infrastructure demand boosts DBM Global, offsetting weakness in Spectrum and Life Sciences.

INNOVATE NYSE: VATE reported higher first-quarter revenue and a narrower loss as growth in its infrastructure business offset weaker results in its Life Sciences and Spectrum segments, management said on the company's first-quarter 2026 earnings call.

INNOVATE Corp. (VATE) Q1 2026 Earnings Call Prepared Remarks Transcript

- Infrastructure: Strong first quarter results with revenue of  $357.9 million - Life Sciences: MediBeacon receives the CE mark for the Transdermal GFR Monitor and Reusable Sensor - Spectrum: More than 60 new license applications filed to expand national footprint and increase population coverage NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- INNOVATE Corp. (“INNOVATE” or the “Company”) (NYSE: VATE) announced today its consolidated results for the first quarter. Financial Summary (in millions, except per share amounts) Three Months Ended March 31,   2026   2025   Increase / (Decrease) Revenue $ 364.8     $ 274.2     33.0 % Net loss attributable to common stockholders and participating preferred stockholders $ (17.2 )   $ (24.8 )   30.6 % Basic and Diluted loss per share attributable to common stockholders $ (1.29 )   $ (1.89 )   31.7 % Total Adjusted EBITDA(1) $ 19.7     $ 7.2     173.6 % (1) Reconciliation of GAAP to Non-GAAP measures follows   Commentary "INNOVATE delivered a strong start to the year, with solid execution and improving visibility across the portfolio,” said Avie Glazer, Chairman of INNOVATE.

NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that it will release its financial results for the first quarter 2026 on Thursday, May 14, 2026, after market close. The Company will host an earnings conference call reviewing these results, its operations and strategy on the same day, beginning at 4:30 p.m. ET.

NEW YORK, April 06, 2026 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that DBM Global Inc. (“DBMG”), a family of companies providing fully integrated steel construction services, and an operating subsidiary of INNOVATE, will pay a cash dividend of approximately $3 million, or $0.78 per share, on April 28, 2026 to DBMG's stockholders of record at the close of business on April 13, 2026. As the largest stockholder of DBMG, INNOVATE expects to receive approximately $2.7 million of the total $3 million dividend payout. INNOVATE's individual stockholders are not eligible to receive the cash dividend.

NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that MediBeacon Inc. (“MediBeacon”), a medical technology company specializing in the advancement of fluorescent tracer agents and their transdermal detection, and an equity method investment of INNOVATE, announced receipt of European Union (EU) CE Mark certification under the EU Medical Device Regulation (MDR) for its TGFR™ Monitor and TGFR™ Reusable Sensor. The certification confirms that the Monitor and Sensor have met the robust safety, quality, and performance standards required under the EU MDR 2017/745.

INNOVATE Corp. (VATE) Q4 2025 Earnings Call Prepared Remarks Transcript

- Infrastructure: NYC and Western markets continue to demonstrate positive project momentum - - Life Sciences: R2 Secures 600‑System Commitment in China - - Spectrum: Recent network launches set to deliver benefits beginning in 2026 -